Moderna Inc. requests authorization for COVID-19 vaccine
Moderna Inc. requests authorization of emergency use for the coronavirus (COVID-19) vaccine with regulators in the U.S. and Europe. This request follows the exciting and promising results of the COVID-19 vaccine trials proving 94% effective in the final analysis of the Phase 3 trial.
Moderna’s Phase 3 trial included nearly 30,000 volunteers with 196 patients developing COVID-19 but a majority of these cases were observed in the placebo group. These promising results were the final step Moderna needed before applying for emergency use of the COVID-19 vaccine with U.S. and European regulators.
BREAKING NEWS: Moderna to file for emergency FDA approval in the race for a vaccine. https://t.co/iplMX9Br3V pic.twitter.com/0kGIy0APxR
— Good Morning America (@GMA) November 30, 2020
The Moderna vaccine will be available in shot form and the study results prove that this vaccine offers strong protection against COVID-19. Moderna is the third pharmaceutical company to apply for emergency vaccine use with Pfizer and BioNTech applying for emergency use on Nov. 20 in the U.S. as well as the UK who is also assessing the AstraZeneca vaccine.
The next step of the FDA approval process is to hold a public debate with scientific advisors on the evidence of each participating candidate for the study. Once approved, Moderna expects to have 20 million doses ready for the U.S. by the end of 2020 with recipients will need two doses and will ultimately provide enough for 10 million patients.
The manufacturing process has already begun and Moderna is ready to start sending out shipments of the vaccine within 24 hours of FDA clearance. A separate panel of U.S. experts designated by the Center for Disease Control and Prevention (CDC) will create a strategy for the distribution of who will receive the initial supplies first.
The initial distribution plan will reserve some doses for health care workers, then the elderly and long-term care facility residents. If everything goes according to plan and the vaccine is approved, Moderna Inc. will be able to provide enough of the vaccine for the general public by Spring 2021.
Simple Snacks For The Keto Diet
-
A transformative partnership to boost biodiversity, resilience, and gender equality in the face of climate change. The Philippines, in...
-
Claims by the ‘Crimea Combat Seagulls’ of poisoning two dozen Russian soldiers raise questions, prompting scrutiny and calls for...
-
According to the latest annual report from the Tokyo metropolitan government, Tokyo finds itself at the bottom of Japan’s...
-
A revealing look at the tensions, beliefs, and family dynamics within the British royal family In his latest book,...
-
A single-engine aircraft en route from the Czech Republic to Croatia crashes in western Austria, prompting an investigation into...
-
Historic Bust: Massive Counterfeit Coin Operation Exposed, Unveiling Unprecedented Scale of Fake Toonies in Canada. In a groundbreaking development,...
-
Global leaders from BRICS urge restraint, humanitarian truce, and diplomatic solutions to quell the Israel-Hamas tensions. In a landmark...
-
Secretary of State Antony Blinken calls for de-escalation as fighting displaces millions and raises concerns for upcoming Congo elections....
-
The government is taking action to stop the spread of the bloodsucking pests. The South Korean government has launched...
-
Landmark ruling highlights ongoing tax challenges for short-term rental platforms in Italy In a significant development, an Italian judge...
-
Deportation Deadline Sparks Humanitarian Worries in Pakistan Pakistan’s government announced on Monday that almost 200,000 Afghan nationals have voluntarily...
-
Lessons Learned Shape Taiwan’s Preparedness in a Changing World Taiwan’s military has embarked on a comprehensive initiative to strengthen...